Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative stress

Podolsky, 2002, Inflammatory bowel disease, N. Engl. J. Med., 347, 417, 10.1056/NEJMra020831 Aychek, 2014, Immunology, axis Toler. Sci., 343, 1439 Maloy, 2011, Intestinal homeostasis and its breakdown in inflammatory bowel disease, Nature, 474, 298, 10.1038/nature10208 Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect. Immun., 66, 5224, 10.1128/IAI.66.11.5224-5231.1998 Vijay-Kumar, 2007, Deletion of TLR5 results in spontaneous colitis in mice, J. Clin. Investig., 117, 3909 Strowig, 2012, Inflammasomes in health and disease, Nature, 481, 278, 10.1038/nature10759 Latz, 2013, Activation and regulation of the inflammasomes, Nat. Rev. Immunol., 13, 397, 10.1038/nri3452 Filardy, 2016, Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages, Mucosal Immunol., 9, 850, 10.1038/mi.2015.109 Bruchard, 2013, Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat. Med., 19, 57, 10.1038/nm.2999 Franchi, 2009, The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis, Nat. Immunol., 10, 241, 10.1038/ni.1703 Schroder, 2010, The inflammasomes, Cell, 140, 821, 10.1016/j.cell.2010.01.040 Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta, Nat. Immunol., 9, 857, 10.1038/ni.1636 De Nardo, 2011, NLRP3 inflammasomes link inflammation and metabolic disease, Trends Immunol., 32, 373, 10.1016/j.it.2011.05.004 Abderrazak, 2015, NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases, Redox Biol., 4, 296, 10.1016/j.redox.2015.01.008 Bauer, 2010, Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome, Gut, 59, 1192, 10.1136/gut.2009.197822 Mao, 2013, Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock, Cell Res., 23, 201, 10.1038/cr.2013.6 Han, 2015, Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation, Int. J. Mol. Sci., 16, 8102, 10.3390/ijms16048102 Havsteen, 1983, Flavonoids, a class of natural products of high pharmacological potency, Biochem. Pharmacol., 32, 1141, 10.1016/0006-2952(83)90262-9 Honda, 2014, Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation, J. Leukoc. Biol., 96, 1087, 10.1189/jlb.3A0114-005RR Tsai, 2011, Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation, Free Radic. Biol. Med., 51, 744, 10.1016/j.freeradbiomed.2011.05.016 White, 2012, Some natural flavonoids are competitive inhibitors of Caspase-1, -3 and -7 despite their cellular toxicity, Food Chem., 131, 1453, 10.1016/j.foodchem.2011.10.026 Nowarski, 2015, Epithelial IL-18 equilibrium controls barrier function in colitis, Cell, 163, 1444, 10.1016/j.cell.2015.10.072 Dostert, 2008, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, Science, 320, 674, 10.1126/science.1156995 Goldman, 2010, Autophagy and the degradation of mitochondria, Mitochondrion, 10, 309, 10.1016/j.mito.2010.01.005 Nishiyama, 1999, Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression, J. Biol. Chem., 274, 21645, 10.1074/jbc.274.31.21645 Chi, 2001, Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases, Biochem. Pharmacol., 62, 1185, 10.1016/S0006-2952(01)00773-0 Middleton, 2000, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev., 52, 673 Kim, 2004, Anti-inflammatory plant flavonoids and cellular action mechanisms, J. Pharmacol. Sci., 96, 229, 10.1254/jphs.CRJ04003X Lim, 2011, Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-1beta-treated articular chondrocytes and their cellular mechanisms: inhibition of c-Fos/AP-1 and JAK/STAT signaling pathways, J. Pharmacol. Sci., 116, 221, 10.1254/jphs.11014FP Choi, 2017, Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: critical role of PPAR-gamma signaling pathway, Biochem. Pharmacol., 144, 120, 10.1016/j.bcp.2017.07.021 Zhou, 2017, Apigenin inhibits d-galactosamine/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARgamma expressions in mice, Biochem. Biophys. Res. Commun., 493, 625, 10.1016/j.bbrc.2017.08.141 Rodriguez-Mateos, 2014, Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update, Arch. Toxicol., 88, 1803, 10.1007/s00204-014-1330-7 Danese, 2011, Colitis-associated cancer: the dark side of inflammatory bowel disease, Gut, 60, 1609, 10.1136/gutjnl-2011-300953 Rutgeerts, 2004, Optimizing anti-TNF treatment in inflammatory bowel disease, Gastroenterology, 126, 1593, 10.1053/j.gastro.2004.02.070 Faubion, 2001, The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study, Gastroenterology, 121, 255, 10.1053/gast.2001.26279 Beaugerie, 2009, Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, Lancet, 374, 1617, 10.1016/S0140-6736(09)61302-7 Lamkanfi, 2012, The inflammasome: a remote control for metabolic syndrome, Cell Res., 22, 1095, 10.1038/cr.2012.55 Takahashi, 2007, Decreased expression of thioredoxin interacting protein mRNA in inflamed colonic mucosa in patients with ulcerative colitis, Oncol. Rep., 18, 531 Kowaltowski, 2009, Mitochondria and reactive oxygen species, Free Radic. Biol. Med., 47, 333, 10.1016/j.freeradbiomed.2009.05.004 Abais, 2014, Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia, J. Biol. Chem., 289, 27159, 10.1074/jbc.M114.567537 Zhong, 2016, NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria, Cell, 164, 896, 10.1016/j.cell.2015.12.057 Zhao, 2017, Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy, Oncoimmunology, 7, e1375640, 10.1080/2162402X.2017.1375640 Zhao, 2015, GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway, Oncotarget, 6, 26291, 10.18632/oncotarget.4657 Wang, 2017, An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells, Mucosal Immunol., 10, 373, 10.1038/mi.2016.57 Zhao, 2015, LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells, Apoptosis: Int. J. Program. Cell Death, 20, 1253, 10.1007/s10495-015-1145-x